Search

everythinglearnresearchcommunity

for

Search:↓

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Type 2 5α-reductase plays a key role in hair loss.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Gene differences may affect baldness treatment response in Korean men.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New compounds were made that are promising for prostate cancer therapy.

The compounds tested could potentially treat hair loss and alopecia.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

OR2AT4 helps reduce aging and cell damage in human skin cells.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.